Summary

Molecular robots are tiny robots that are made up of molecules that are able to perform tasks at the molecular level. This technology has the potential to revolutionize healthcare by performing tasks at the cellular and molecular level including targeted drug delivery, diagnostics, and surgeries. The higher prevalence of chronic diseases such as cancer, and pulmonary disorders and the increasing efforts in the development of new technology for disease treatment are responsible for the market growth of molecular robots. For instance, according to the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.

The Molecular Robots Market is expected to grow at a steady rate of around 18% owing to the advancements in robotic technology and the increasing investments of market players in the technology. For instance, in January 2020, Eli Lilly and Company and Strateos, Inc. unveiled a new robotic laboratory in San Diego, California designed to accelerate the drug discovery process.

• Based on the application, the market has been categorized into drug discovery, genetic research, and others. Among them, the drug discovery segment holds a dominant share of the market in 2021. The rapid development in molecular nanotechnology, along with the rising demand for the targeted drug due to the increasing prevalence of many diseases attributed to the rising demand for drug research programs.

• Based on the end-user, the market has been categorized into research laboratories, pharma and biotech companies, and others. Among them, the pharma and biotech companies segment is anticipated to witness the fastest growth in the market. The increasing use of molecular robots is used in the manufacturing of drugs, early diagnosis of a disease, and drug delivery attributed to the growth of the segment.

• For a better understanding of the market adoption of the molecular robots industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated to hold a dominant market share in 2021. This is mainly due to the increasing efforts in the research and development of robotics along with the higher investments in research & development attributed to the market growth of molecular robots in the region. For instance, according to the National Science Foundation, USD 666.9 billion was spent on research and experimental development (R&D) in the US in 2019..

• Some of the major players operating in the market are Bruker; Danaher; Entos, Inc.; Hudson Robotics; Imina Technologies SA; IBM; Klocke Nanotechnik GmbH; Labplan; Nanorobotics; and PerkinElmer Inc.

ページTOPに戻る

Table of Contents